Aylin Alasonyalilar Demirer
Overview
Explore the profile of Aylin Alasonyalilar Demirer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shirian J, Hockla A, Gleba J, Coban M, Rotenberg N, Strik L, et al.
Biomolecules
. 2024 Sep;
14(9).
PMID: 39334953
Matrix metalloproteinases (MMPs) are significant drivers of many diseases, including cancer, and are established targets for drug development. Tissue inhibitors of metalloproteinases (TIMPs) are endogenous MMP inhibitors and are being...
2.
Shirian J, Hockla A, Gleba J, Coban M, Rotenberg N, Strik L, et al.
bioRxiv
. 2024 Jul;
PMID: 38979353
Matrix Metalloproteinases (MMPs) are drivers of many diseases including cancer and are established targets for drug development. Tissue inhibitors of metalloproteinases (TIMPs) are human proteins that inhibit MMPs and are...
3.
Kase A, Gleba J, Miller J, Miller E, Petit J, Barrett M, et al.
Mol Cancer Ther
. 2024 Mar;
23(6):823-835.
PMID: 38442920
Metastatic castration-resistant prostate cancer (mCRPC) is an aggressive malignancy with poor outcomes. To investigate novel therapeutic strategies, we characterized three new metastatic prostate cancer patient derived-tumor xenograft (PDTX) models and...